 | • レポートコード：QAF27921 • 出版社/出版日：QYResearch / 2021年4月9日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のチロシンキナーゼJAK阻害剤市場について種類別（トファシチニブ、ルキソリチニブ、バリシチニブ）、用途別（関節リウマチ（RA）、真性多血症（PCV）、骨髄線維症（MF）、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・チロシンキナーゼJAK阻害剤市場の概要 ・世界の主要地域別チロシンキナーゼJAK阻害剤市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のチロシンキナーゼJAK阻害剤市場規模2016-2021：種類別（トファシチニブ、ルキソリチニブ、バリシチニブ） ・世界のチロシンキナーゼJAK阻害剤市場予測2012-2027：種類別（トファシチニブ、ルキソリチニブ、バリシチニブ） ・世界のチロシンキナーゼJAK阻害剤市場規模2016-2021：用途別（関節リウマチ（RA）、真性多血症（PCV）、骨髄線維症（MF）、その他） ・世界のチロシンキナーゼJAK阻害剤市場予測2012-2027：用途別（関節リウマチ（RA）、真性多血症（PCV）、骨髄線維症（MF）、その他） ・チロシンキナーゼJAK阻害剤のアメリカ市場規模と予測2016-2021 ・チロシンキナーゼJAK阻害剤のヨーロッパ市場規模と予測2016-2021 ・チロシンキナーゼJAK阻害剤の中国市場規模と予測2016-2021 ・チロシンキナーゼJAK阻害剤の日本市場規模と予測2016-2021 ・チロシンキナーゼJAK阻害剤の東南アジア市場規模と予測2016-2021 ・チロシンキナーゼJAK阻害剤のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、Incyte、Novartis、Eli Lilly、Gilead、Sanofi、Galapagos、AbbVie、Vertex、Teva、Astellas Pharma、Celgene、CTI BioPharma） ・チロシンキナーゼJAK阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・チロシンキナーゼJAK阻害剤の市場動向・機会・課題 ・調査の結論 |
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.
These inhibitors have therapeutic application in the treatment of cancer and inflammatory diseases such as rheumatoid arthritis. There is interest in their use for various skin conditions. JAK3 inhibitors are attractive as a possible treatment of various autoimmune diseases since its functions is mainly restricted to lymphocytes. Development for a selective JAK3 inhibitors are ongoing.
In the report, we only count drugs for human beings. And the 1 unit is 1 tablet.
Tyrosine Kinase JAK Inhibitors is widely used in Rheumatoid Arthritis (RA), Polycythemia Vera (PCV) and Myelofibrosis (MF). The most proportion of Tyrosine Kinase JAK Inhibitors is for Rheumatoid Arthritis (RA), and the proportion in 2017 is about 37%.
Market Analysis and Insights: Global Tyrosine Kinase JAK Inhibitors Market
The global Tyrosine Kinase JAK Inhibitors market was valued at US$ 24110 in 2020 and will reach US$ 191900 million by the end of 2027, growing at a CAGR of 41.3% during 2022-2027.
Global Tyrosine Kinase JAK Inhibitors Scope and Market Size
The global Tyrosine Kinase JAK Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tyrosine Kinase JAK Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Tofacitinib
Ruxolitinib
Baricitinib
Segment by Application
Rheumatoid Arthritis (RA)
Polycythemia Vera (PCV)
Myelofibrosis (MF)
Others
The Tyrosine Kinase JAK Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Tyrosine Kinase JAK Inhibitors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Pfizer
Incyte
Novartis
Eli Lilly
Gilead
Sanofi
Galapagos
AbbVie
Vertex
Teva
Astellas Pharma
Celgene
CTI BioPharma
1 Tyrosine Kinase JAK Inhibitors Market Overview
1.1 Tyrosine Kinase JAK Inhibitors Product Scope
1.2 Tyrosine Kinase JAK Inhibitors Segment by Type
1.2.1 Global Tyrosine Kinase JAK Inhibitors Sales by Type (2016 & 2021 & 2027)
1.2.2 Tofacitinib
1.2.3 Ruxolitinib
1.2.4 Baricitinib
1.3 Tyrosine Kinase JAK Inhibitors Segment by Application
1.3.1 Global Tyrosine Kinase JAK Inhibitors Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Rheumatoid Arthritis (RA)
1.3.3 Polycythemia Vera (PCV)
1.3.4 Myelofibrosis (MF)
1.3.5 Others
1.4 Tyrosine Kinase JAK Inhibitors Market Estimates and Forecasts (2016-2027)
1.4.1 Global Tyrosine Kinase JAK Inhibitors Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Tyrosine Kinase JAK Inhibitors Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Tyrosine Kinase JAK Inhibitors Price Trends (2016-2027)
2 Tyrosine Kinase JAK Inhibitors Estimates and Forecasts by Region
2.1 Global Tyrosine Kinase JAK Inhibitors Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Tyrosine Kinase JAK Inhibitors Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Region (2016-2021)
2.2.2 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Region (2016-2021)
2.3 Global Tyrosine Kinase JAK Inhibitors Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Tyrosine Kinase JAK Inhibitors Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Tyrosine Kinase JAK Inhibitors Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Tyrosine Kinase JAK Inhibitors Estimates and Projections (2016-2027)
2.4.2 Europe Tyrosine Kinase JAK Inhibitors Estimates and Projections (2016-2027)
2.4.3 China Tyrosine Kinase JAK Inhibitors Estimates and Projections (2016-2027)
2.4.4 Japan Tyrosine Kinase JAK Inhibitors Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Tyrosine Kinase JAK Inhibitors Estimates and Projections (2016-2027)
2.4.6 India Tyrosine Kinase JAK Inhibitors Estimates and Projections (2016-2027)
3 Global Tyrosine Kinase JAK Inhibitors Competition Landscape by Players
3.1 Global Top Tyrosine Kinase JAK Inhibitors Players by Sales (2016-2021)
3.2 Global Top Tyrosine Kinase JAK Inhibitors Players by Revenue (2016-2021)
3.3 Global Tyrosine Kinase JAK Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tyrosine Kinase JAK Inhibitors as of 2020)
3.4 Global Tyrosine Kinase JAK Inhibitors Average Price by Company (2016-2021)
3.5 Manufacturers Tyrosine Kinase JAK Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Tyrosine Kinase JAK Inhibitors Market Size by Type
4.1 Global Tyrosine Kinase JAK Inhibitors Historic Market Review by Type (2016-2021)
4.1.1 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2016-2021)
4.1.2 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Type (2016-2021)
4.1.3 Global Tyrosine Kinase JAK Inhibitors Price by Type (2016-2021)
4.2 Global Tyrosine Kinase JAK Inhibitors Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Type (2022-2027)
4.2.2 Global Tyrosine Kinase JAK Inhibitors Revenue Forecast by Type (2022-2027)
4.2.3 Global Tyrosine Kinase JAK Inhibitors Price Forecast by Type (2022-2027)
5 Global Tyrosine Kinase JAK Inhibitors Market Size by Application
5.1 Global Tyrosine Kinase JAK Inhibitors Historic Market Review by Application (2016-2021)
5.1.1 Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2016-2021)
5.1.2 Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Application (2016-2021)
5.1.3 Global Tyrosine Kinase JAK Inhibitors Price by Application (2016-2021)
5.2 Global Tyrosine Kinase JAK Inhibitors Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Tyrosine Kinase JAK Inhibitors Sales Forecast by Application (2022-2027)
5.2.2 Global Tyrosine Kinase JAK Inhibitors Revenue Forecast by Application (2022-2027)
5.2.3 Global Tyrosine Kinase JAK Inhibitors Price Forecast by Application (2022-2027)
6 North America Tyrosine Kinase JAK Inhibitors Market Facts & Figures
6.1 North America Tyrosine Kinase JAK Inhibitors Sales by Company
6.1.1 North America Tyrosine Kinase JAK Inhibitors Sales by Company (2016-2021)
6.1.2 North America Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021)
6.2 North America Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type
6.2.1 North America Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2016-2021)
6.2.2 North America Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2022-2027)
6.3 North America Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application
6.3.1 North America Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application (2016-2021)
6.3.2 North America Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application (2022-2027)
7 Europe Tyrosine Kinase JAK Inhibitors Market Facts & Figures
7.1 Europe Tyrosine Kinase JAK Inhibitors Sales by Company
7.1.1 Europe Tyrosine Kinase JAK Inhibitors Sales by Company (2016-2021)
7.1.2 Europe Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021)
7.2 Europe Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type
7.2.1 Europe Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2016-2021)
7.2.2 Europe Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2022-2027)
7.3 Europe Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application
7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)
8 China Tyrosine Kinase JAK Inhibitors Market Facts & Figures
8.1 China Tyrosine Kinase JAK Inhibitors Sales by Company
8.1.1 China Tyrosine Kinase JAK Inhibitors Sales by Company (2016-2021)
8.1.2 China Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021)
8.2 China Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type
8.2.1 China Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2016-2021)
8.2.2 China Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2022-2027)
8.3 China Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Tyrosine Kinase JAK Inhibitors Market Facts & Figures
9.1 Japan Tyrosine Kinase JAK Inhibitors Sales by Company
9.1.1 Japan Tyrosine Kinase JAK Inhibitors Sales by Company (2016-2021)
9.1.2 Japan Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021)
9.2 Japan Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type
9.2.1 Japan Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2016-2021)
9.2.2 Japan Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2022-2027)
9.3 Japan Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Tyrosine Kinase JAK Inhibitors Market Facts & Figures
10.1 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales by Company
10.1.1 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales by Company (2016-2021)
10.1.2 Southeast Asia Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021)
10.2 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type
10.2.1 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Tyrosine Kinase JAK Inhibitors Market Facts & Figures
11.1 India Tyrosine Kinase JAK Inhibitors Sales by Company
11.1.1 India Tyrosine Kinase JAK Inhibitors Sales by Company (2016-2021)
11.1.2 India Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021)
11.2 India Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type
11.2.1 India Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2016-2021)
11.2.2 India Tyrosine Kinase JAK Inhibitors Sales Breakdown by Type (2022-2027)
11.3 India Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application
11.3.1 India Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application (2016-2021)
11.3.2 India Tyrosine Kinase JAK Inhibitors Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Tyrosine Kinase JAK Inhibitors Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Tyrosine Kinase JAK Inhibitors Products Offered
12.1.5 Pfizer Recent Development
12.2 Incyte
12.2.1 Incyte Corporation Information
12.2.2 Incyte Business Overview
12.2.3 Incyte Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Incyte Tyrosine Kinase JAK Inhibitors Products Offered
12.2.5 Incyte Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Novartis Tyrosine Kinase JAK Inhibitors Products Offered
12.3.5 Novartis Recent Development
12.4 Eli Lilly
12.4.1 Eli Lilly Corporation Information
12.4.2 Eli Lilly Business Overview
12.4.3 Eli Lilly Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eli Lilly Tyrosine Kinase JAK Inhibitors Products Offered
12.4.5 Eli Lilly Recent Development
12.5 Gilead
12.5.1 Gilead Corporation Information
12.5.2 Gilead Business Overview
12.5.3 Gilead Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Gilead Tyrosine Kinase JAK Inhibitors Products Offered
12.5.5 Gilead Recent Development
12.6 Sanofi
12.6.1 Sanofi Corporation Information
12.6.2 Sanofi Business Overview
12.6.3 Sanofi Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sanofi Tyrosine Kinase JAK Inhibitors Products Offered
12.6.5 Sanofi Recent Development
12.7 Galapagos
12.7.1 Galapagos Corporation Information
12.7.2 Galapagos Business Overview
12.7.3 Galapagos Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Galapagos Tyrosine Kinase JAK Inhibitors Products Offered
12.7.5 Galapagos Recent Development
12.8 AbbVie
12.8.1 AbbVie Corporation Information
12.8.2 AbbVie Business Overview
12.8.3 AbbVie Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.8.4 AbbVie Tyrosine Kinase JAK Inhibitors Products Offered
12.8.5 AbbVie Recent Development
12.9 Vertex
12.9.1 Vertex Corporation Information
12.9.2 Vertex Business Overview
12.9.3 Vertex Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Vertex Tyrosine Kinase JAK Inhibitors Products Offered
12.9.5 Vertex Recent Development
12.10 Teva
12.10.1 Teva Corporation Information
12.10.2 Teva Business Overview
12.10.3 Teva Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Tyrosine Kinase JAK Inhibitors Products Offered
12.10.5 Teva Recent Development
12.11 Astellas Pharma
12.11.1 Astellas Pharma Corporation Information
12.11.2 Astellas Pharma Business Overview
12.11.3 Astellas Pharma Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Astellas Pharma Tyrosine Kinase JAK Inhibitors Products Offered
12.11.5 Astellas Pharma Recent Development
12.12 Celgene
12.12.1 Celgene Corporation Information
12.12.2 Celgene Business Overview
12.12.3 Celgene Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Celgene Tyrosine Kinase JAK Inhibitors Products Offered
12.12.5 Celgene Recent Development
12.13 CTI BioPharma
12.13.1 CTI BioPharma Corporation Information
12.13.2 CTI BioPharma Business Overview
12.13.3 CTI BioPharma Tyrosine Kinase JAK Inhibitors Sales, Revenue and Gross Margin (2016-2021)
12.13.4 CTI BioPharma Tyrosine Kinase JAK Inhibitors Products Offered
12.13.5 CTI BioPharma Recent Development
13 Tyrosine Kinase JAK Inhibitors Manufacturing Cost Analysis
13.1 Tyrosine Kinase JAK Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tyrosine Kinase JAK Inhibitors
13.4 Tyrosine Kinase JAK Inhibitors Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tyrosine Kinase JAK Inhibitors Distributors List
14.3 Tyrosine Kinase JAK Inhibitors Customers
15 Market Dynamics
15.1 Tyrosine Kinase JAK Inhibitors Market Trends
15.2 Tyrosine Kinase JAK Inhibitors Drivers
15.3 Tyrosine Kinase JAK Inhibitors Market Challenges
15.4 Tyrosine Kinase JAK Inhibitors Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Tyrosine Kinase JAK Inhibitors Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Tyrosine Kinase JAK Inhibitors Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Tyrosine Kinase JAK Inhibitors Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) by Region (2016-2021)
Table 5. Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Region (2016-2021)
Table 6. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Region (2016-2021)
Table 8. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Tyrosine Kinase JAK Inhibitors Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Tyrosine Kinase JAK Inhibitors Revenue Share Forecast by Region (2022-2027)
Table 12. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Tyrosine Kinase JAK Inhibitors Sales Share by Company (2016-2021)
Table 14. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Company (2016-2021)
Table 16. Global Tyrosine Kinase JAK Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tyrosine Kinase JAK Inhibitors as of 2020)
Table 17. Global Tyrosine Kinase JAK Inhibitors Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Tyrosine Kinase JAK Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers Tyrosine Kinase JAK Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) by Type (2016-2021)
Table 22. Global Tyrosine Kinase JAK Inhibitors Sales Share by Type (2016-2021)
Table 23. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Tyrosine Kinase JAK Inhibitors Price (USD/Unit) by Type (2016-2021)
Table 25. Global Tyrosine Kinase JAK Inhibitors Sales Share by Type (2022-2027)
Table 26. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Type (2022-2027)
Table 28. Global Tyrosine Kinase JAK Inhibitors Price (USD/Unit) by Type (2022-2027)
Table 29. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2016-2021)
Table 30. Global Tyrosine Kinase JAK Inhibitors Sales Share by Application (2016-2021)
Table 31. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Tyrosine Kinase JAK Inhibitors Price (USD/Unit) by Application (2016-2021)
Table 33. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) by Application (2022-2027)
Table 34. Global Tyrosine Kinase JAK Inhibitors Sales Share by Application (2022-2027)
Table 35. Global Tyrosine Kinase JAK Inhibitors Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Application (2022-2027)
Table 37. Global Tyrosine Kinase JAK Inhibitors Price (USD/Unit) by Application (2022-2027)
Table 38. North America Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2016-2021)
Table 39. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2016-2021)
Table 40. North America Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Tyrosine Kinase JAK Inhibitors Revenue Market Share by Company (2016-2021)
Table 42. North America Tyrosine Kinase JAK Inhibitors Sales by Type (2016-2021) & (K Units)
Table 43. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2016-2021)
Table 44. North America Tyrosine Kinase JAK Inhibitors Sales by Type (2022-2027) & (K Units)
Table 45. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2022-2027)
Table 46. North America Tyrosine Kinase JAK Inhibitors Sales by Application (2016-2021) & (K Units)
Table 47. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2016-2021)
Table 48. North America Tyrosine Kinase JAK Inhibitors Sales by Application (2022-2027) & (K Units)
Table 49. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2022-2027)
Table 50. Europe Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2016-2021)
Table 51. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2016-2021)
Table 52. Europe Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Tyrosine Kinase JAK Inhibitors Revenue Market Share by Company (2016-2021)
Table 54. Europe Tyrosine Kinase JAK Inhibitors Sales by Type (2016-2021) & (K Units)
Table 55. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2016-2021)
Table 56. Europe Tyrosine Kinase JAK Inhibitors Sales by Type (2022-2027) & (K Units)
Table 57. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2022-2027)
Table 58. Europe Tyrosine Kinase JAK Inhibitors Sales by Application (2016-2021) & (K Units)
Table 59. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2016-2021)
Table 60. Europe Tyrosine Kinase JAK Inhibitors Sales by Application (2022-2027) & (K Units)
Table 61. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2022-2027)
Table 62. China Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2016-2021)
Table 63. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2016-2021)
Table 64. China Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Tyrosine Kinase JAK Inhibitors Revenue Market Share by Company (2016-2021)
Table 66. China Tyrosine Kinase JAK Inhibitors Sales by Type (2016-2021) & (K Units)
Table 67. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2016-2021)
Table 68. China Tyrosine Kinase JAK Inhibitors Sales by Type (2022-2027) & (K Units)
Table 69. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2022-2027)
Table 70. China Tyrosine Kinase JAK Inhibitors Sales by Application (2016-2021) & (K Units)
Table 71. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2016-2021)
Table 72. China Tyrosine Kinase JAK Inhibitors Sales by Application (2022-2027) & (K Units)
Table 73. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2022-2027)
Table 74. Japan Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2016-2021)
Table 75. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2016-2021)
Table 76. Japan Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Tyrosine Kinase JAK Inhibitors Revenue Market Share by Company (2016-2021)
Table 78. Japan Tyrosine Kinase JAK Inhibitors Sales by Type (2016-2021) & (K Units)
Table 79. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2016-2021)
Table 80. Japan Tyrosine Kinase JAK Inhibitors Sales by Type (2022-2027) & (K Units)
Table 81. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2022-2027)
Table 82. Japan Tyrosine Kinase JAK Inhibitors Sales by Application (2016-2021) & (K Units)
Table 83. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2016-2021)
Table 84. Japan Tyrosine Kinase JAK Inhibitors Sales by Application (2022-2027) & (K Units)
Table 85. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Tyrosine Kinase JAK Inhibitors Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2022-2027)
Table 98. India Tyrosine Kinase JAK Inhibitors Sales (K Units) by Company (2016-2021)
Table 99. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Company (2016-2021)
Table 100. India Tyrosine Kinase JAK Inhibitors Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Tyrosine Kinase JAK Inhibitors Revenue Market Share by Company (2016-2021)
Table 102. India Tyrosine Kinase JAK Inhibitors Sales by Type (2016-2021) & (K Units)
Table 103. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2016-2021)
Table 104. India Tyrosine Kinase JAK Inhibitors Sales by Type (2022-2027) & (K Units)
Table 105. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Type (2022-2027)
Table 106. India Tyrosine Kinase JAK Inhibitors Sales by Application (2016-2021) & (K Units)
Table 107. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2016-2021)
Table 108. India Tyrosine Kinase JAK Inhibitors Sales by Application (2022-2027) & (K Units)
Table 109. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Application (2022-2027)
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Pfizer Tyrosine Kinase JAK Inhibitors Product
Table 114. Pfizer Recent Development
Table 115. Incyte Corporation Information
Table 116. Incyte Description and Business Overview
Table 117. Incyte Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Incyte Tyrosine Kinase JAK Inhibitors Product
Table 119. Incyte Recent Development
Table 120. Novartis Corporation Information
Table 121. Novartis Description and Business Overview
Table 122. Novartis Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Novartis Tyrosine Kinase JAK Inhibitors Product
Table 124. Novartis Recent Development
Table 125. Eli Lilly Corporation Information
Table 126. Eli Lilly Description and Business Overview
Table 127. Eli Lilly Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Eli Lilly Tyrosine Kinase JAK Inhibitors Product
Table 129. Eli Lilly Recent Development
Table 130. Gilead Corporation Information
Table 131. Gilead Description and Business Overview
Table 132. Gilead Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Gilead Tyrosine Kinase JAK Inhibitors Product
Table 134. Gilead Recent Development
Table 135. Sanofi Corporation Information
Table 136. Sanofi Description and Business Overview
Table 137. Sanofi Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Sanofi Tyrosine Kinase JAK Inhibitors Product
Table 139. Sanofi Recent Development
Table 140. Galapagos Corporation Information
Table 141. Galapagos Description and Business Overview
Table 142. Galapagos Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Galapagos Tyrosine Kinase JAK Inhibitors Product
Table 144. Galapagos Recent Development
Table 145. AbbVie Corporation Information
Table 146. AbbVie Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. AbbVie Description and Business Overview
Table 148. AbbVie Tyrosine Kinase JAK Inhibitors Product
Table 149. AbbVie Recent Development
Table 150. Vertex Corporation Information
Table 151. Vertex Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 152. Vertex Description and Business Overview
Table 153. Vertex Tyrosine Kinase JAK Inhibitors Product
Table 154. Vertex Recent Development
Table 155. Teva Corporation Information
Table 156. Teva Description and Business Overview
Table 157. Teva Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 158. Teva Tyrosine Kinase JAK Inhibitors Product
Table 159. Teva Recent Development
Table 160. Astellas Pharma Corporation Information
Table 161. Astellas Pharma Description and Business Overview
Table 162. Astellas Pharma Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 163. Astellas Pharma Tyrosine Kinase JAK Inhibitors Product
Table 164. Astellas Pharma Recent Development
Table 165. Celgene Corporation Information
Table 166. Celgene Description and Business Overview
Table 167. Celgene Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 168. Celgene Tyrosine Kinase JAK Inhibitors Product
Table 169. Celgene Recent Development
Table 170. CTI BioPharma Corporation Information
Table 171. CTI BioPharma Description and Business Overview
Table 172. CTI BioPharma Tyrosine Kinase JAK Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 173. CTI BioPharma Tyrosine Kinase JAK Inhibitors Product
Table 174. CTI BioPharma Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Tyrosine Kinase JAK Inhibitors Distributors List
Table 178. Tyrosine Kinase JAK Inhibitors Customers List
Table 179. Tyrosine Kinase JAK Inhibitors Market Trends
Table 180. Tyrosine Kinase JAK Inhibitors Market Drivers
Table 181. Tyrosine Kinase JAK Inhibitors Market Challenges
Table 182. Tyrosine Kinase JAK Inhibitors Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Tyrosine Kinase JAK Inhibitors Product Picture
Figure 2. Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2021 & 2027
Figure 6. Rheumatoid Arthritis (RA) Examples
Figure 7. Polycythemia Vera (PCV) Examples
Figure 8. Myelofibrosis (MF) Examples
Figure 9. Others Examples
Figure 10. Global Tyrosine Kinase JAK Inhibitors Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Tyrosine Kinase JAK Inhibitors Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Tyrosine Kinase JAK Inhibitors Sales (K Units) Growth Rate (2016-2027)
Figure 13. Global Tyrosine Kinase JAK Inhibitors Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 14. Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Tyrosine Kinase JAK Inhibitors Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Tyrosine Kinase JAK Inhibitors Sales (K Units) Growth Rate (2016-2027)
Figure 18. Europe Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Tyrosine Kinase JAK Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Tyrosine Kinase JAK Inhibitors Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Tyrosine Kinase JAK Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Tyrosine Kinase JAK Inhibitors Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Tyrosine Kinase JAK Inhibitors Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Tyrosine Kinase JAK Inhibitors Players Market Share by Revenue in Tyrosine Kinase JAK Inhibitors: 2016 & 2020
Figure 29. Tyrosine Kinase JAK Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Type (2016-2021)
Figure 31. Global Tyrosine Kinase JAK Inhibitors Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Tyrosine Kinase JAK Inhibitors Revenue Share by Application (2016-2021)
Figure 33. Global Tyrosine Kinase JAK Inhibitors Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2020
Figure 35. North America Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2020
Figure 36. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2020
Figure 37. Europe Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2020
Figure 38. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2020
Figure 39. China Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2020
Figure 40. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2020
Figure 41. Japan Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2020
Figure 42. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2020
Figure 43. Southeast Asia Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2020
Figure 44. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Type in 2020
Figure 45. India Tyrosine Kinase JAK Inhibitors Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Tyrosine Kinase JAK Inhibitors
Figure 48. Manufacturing Process Analysis of Tyrosine Kinase JAK Inhibitors
Figure 49. Tyrosine Kinase JAK Inhibitors Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
非チロシンキナーゼ阻害剤のグローバル市場調査 2019年 The global Non-Tyrosine Kinase Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non-Tyrosine Kinase Inhibitors volume and value at global level, regional level and company level. From a gl…- 世界のチロシンプロテインキナーゼ受容体TYRO3市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tyrosine Protein Kinase Receptor TYRO3 Market The global Tyrosine Protein Kinase Receptor TYRO3 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis a…
- 世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年） JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy in the treatment of various chronic diseases. The high unmet need for the treatment of graft-versus-host disease (GVHD) has also encouraged market vend…
- チロシンプロテインキナーゼCSKのグローバル市場調査 2019年 The global Tyrosine Protein Kinase CSK market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase CSK volume and value at global level, regional level and company level. From a global p…
- チロシンプロテインキナーゼCSKのグローバル市場調査 2019年 The global Tyrosine Protein Kinase CSK market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase CSK volume and value at global level, regional level and company level. From a global p…